Christopher Tame

Part of the pioneering team at GSK who established the field of Targeted Protein Degradation in collaboration with Craig Crews and Alessio Ciulli. Helped to conceive and build biomedical knowledge graphs and data science platforms for drug discovery at Benevolent AI. Delivered multiple drugs to clinical trials.